Frank DiCosmo, Ph.D.
President and Chief Executive Officer

Frank is a scientific innovator in the fields of applied biochemistry, biotechnology and biomedical engineering. He has expertise in biochemistry of anticancer drugs of plant origin, taxol, vinblastine, vincristine, liposome delivery of anticancer agents and inventor of Covalon products and holds several US and European patents. Frank is Professor Emeritus (University of Toronto). He is an Adjunct Professor, Institute of Biomedical Engineering, and the Department of Surgery also at the University of Toronto. Frank began the work that helped form Covalon, and has been with Covalon since its inception.

Valerio DiTizio, Ph.D.
Chief Scientific Officer

Val is the co-inventor on Covalon technologies. He has degrees in science from the University of Toronto as a Biochemistry Specialist. Val completed his Master's degree in liposome drug delivery at the University of Toronto. His graduate research involved the application of polymer chemistry and drug delivery in pursuit of novel materials and processes that currently comprise the core of Covalon’s intellectual property. Val holds several US and European patents. He has been with Covalon since its inception.

William Jackson
Chief Business Officer

William has fifteen years of medical device experience. He has been a successful enterpreneur taking start-ups to market leader, and specializes in building relationships, partnerships and sales. His experience includes sales with Karl Storz Endoscopy (first agent to grow territory by $1 million in first year), was a top ten sales performer for Stryker Corporation, member of the president's Council of Stryker Corporation, co-founder and president of Quick Stitch, co-founder of Preferred Medical Products (a start-up catheter manufacturer company, sold to Ballard medical), and VP Finance for TIME process. William has an undergraduate degree in Honours Business Administration and a graduate degree in Accounting. He has been with Covalon since its inception.

Sonia Sanhueza, Ph.D.
Chief Operating Officer

Sonia has more than 20 years of industry experience. She graduated as a Biochemist from the Universidad de Concepción, Chile, was a Professor at the University Austral, Chile, and continued her post-graduate studies at The Weizmann Institute of Science, Israel, where she first studied crystallography and further obtained her Doctoral degree in Biochemistry. She was a post-doctoral fellow at the University of Toronto studying molecular virology. Dr. Sanhueza has worked for large and medium size biological, pharmaceutical and medical device companies such as Sanofi-Pasteur, ApoPharma and Millenium Biologics. She has filed patents in the vaccine field, lead large multinational R&D projects, responsible for regulatory strategies for anticancer and respiratory tract infections vaccines, obtained product license approval world-wide and lead strategic initiatives. She joined Covalon Technologies in November 2006.